Pediatric Brain Tumor Foundation
Working to eliminate the challenges
of childhood brain tumors
Please leave this field empty

Cure the kids! Give Now

font size AAA

PBTF partners with Siemens to deliver hearing aids



  Cancer patients will benefit from PBTF-Siemens partnership
  Pediatric cancer patients with hearing loss as a result of their treatment will benefit from the PBTF-Siemens partnership.

The Pediatric Brain Tumor Foundation is partnering with Siemens Hearing Instruments, Inc., to distribute top-of-the-line hearing aids and audiology services to patients with brain tumors and other forms of childhood cancer.

Siemens has committed to an in-kind donation of hearing aids and audiology services valued at $1 million to the program, which benefits patients who have permanent hearing loss as a result of cancer treatment – a condition known as ototoxicity.

The PBTF and CancerCare will distribute the hearing aids through a network of hospitals, including Children’s National Health System and the University of Texas: MD Anderson Cancer Center.

"Hearing loss significantly affects quality of life – but in many cases can be remedied," said Scott Davis, CEO, Siemens Hearing Instruments. "By partnering with these two recognized organizations and their network of leading cancer institutions, we’re able to provide the gift of hearing to as many patients as possible.”

The hearing aid donation complements “The Baton Pass™” campaign launched last week, through which Siemens pledged to donate up to $1 million in research funds to Stand Up To Cancer for accelerated cancer research.

The donation also aims to raise awareness about the phenomenon of ototoxicity among platinum-based chemotherapy medications, radiation therapy and other regimens used to treat brain, lung, ovarian and other types of cancers. Although widely successful in treating cancer, these treatments may also damage healthy cochlear hair cells found in the inner ear – often resulting in irreversible hearing loss.

Left untreated, hearing loss has been associated with depression, early signs of dementia and other diseases in adults and delayed or compromised cognitive development and speech and language skills in children.

“Treatment-induced hearing deficits may one day be preventable – a thing of the past – for all young survivors of brain cancer. Until then, the availability of hearing aids is critical,” said Joanne Salcido, Ph.D., PBTF vice president of research and family support. “Thanks to Siemens’ generous contribution and commitment, the Pediatric Brain Tumor Foundation is able to make a difference for children today.”

Siemens is also providing onsite audiology support through its educational team as well as a dedicated customer service and technical support line for the participating hospitals.

The Pediatric Brain Tumor Foundation, a national voluntary health nonprofit based in Asheville, N.C., is the world's largest non-governmental funder of childhood brain tumor research. More than 28,000 children in the United States are living with a brain tumor, and 13 more cases are identified each day. Our programs also include free educational resources and special events for brain tumor survivors and their families. For more information, call 800-253-6530 or go to

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros. For further information please visit: